Calcium channel blockers: current controversies and basic mechanisms of action.
Clusin
W T
WT
Cardiology Division, Stanford University School of Medicine, California 94305, USA.
Anderson
M E
ME
D000818:Animals; D001665:Binding Sites; D002118:Calcium / Q000378:metabolism; D002121:Calcium Channel Blockers / Q000494:pharmacology* / Q000627:therapeutic use; D015220:Calcium Channels / Q000737:chemistry / Q000145:classification / Q000187:drug effects*; D020746:Calcium Channels, L-Type; D017868:Cyclic AMP-Dependent Protein Kinases / Q000502:physiology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D015640:Ion Channel Gating; D009203:Myocardial Infarction / Q000517:prevention & control; D017202:Myocardial Ischemia / Q000188:drug therapy; D011493:Protein Kinase C / Q000502:physiology
D002121:Calcium Channel Blockers; D015220:Calcium Channels; D020746:Calcium Channels, L-Type; D017868:Cyclic AMP-Dependent Protein Kinases; D011493:Protein Kinase C; D002118:Calcium